All Board proposals approved by the Shareholders Allschwil, Switzerland - May 4, 2023At today's Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders
All Board proposals approved by the Shareholders Allschwil, Switzerland – May 4, 2023At today’s Annual General Meeting of Idorsia Ltd held in Basel, Switzerland, shareholders voted in. | May 4, 2023
QUVIVIQ is indicated for the management of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.Idorsia Canada - led by General Manager Ron Morcos - aims
Idorsia (OTCMKTS:IDRSF – Get Rating) was downgraded by stock analysts at Credit Suisse Group from a “neutral” rating to an “underperform” rating in a research note issued to investors on Wednesday, The Fly reports. A number of other research analysts have also weighed in on IDRSF. Deutsche Bank Aktiengesellschaft lowered Idorsia from a “hold” rating […]
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - April 25, 2023 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2023. Commercial highlights QUVIVIQ